Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Analysis of changes in adipose tissue of patients infected with HIV and lipoatrophy treated with nucleoside thymidine, after a switch to monotherapy with lopinavir/ritonavir [Analisis de Los Cambios en el Tejido Adiposo de Pacientes Con infeccion VIH y Lipoatrofia en Tratamiento Con analogos de nucleosidos timidinicos, Tras el Cambio a Monoterapia Con Lopinavir/Ritonavir]

Trial Profile

Analysis of changes in adipose tissue of patients infected with HIV and lipoatrophy treated with nucleoside thymidine, after a switch to monotherapy with lopinavir/ritonavir [Analisis de Los Cambios en el Tejido Adiposo de Pacientes Con infeccion VIH y Lipoatrofia en Tratamiento Con analogos de nucleosidos timidinicos, Tras el Cambio a Monoterapia Con Lopinavir/Ritonavir]

Status: Discontinued
Phase of Trial: Phase IV

Latest Information Update: 08 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lopinavir/ritonavir (Primary) ; Lamivudine/zidovudine/abacavir
  • Indications HIV-1 infections
  • Focus Pharmacodynamics
  • Acronyms BIOKAL
  • Most Recent Events

    • 10 Dec 2012 Status changed from suspended to discontinued.
    • 10 Dec 2012 Status changed from recruiting to suspended.
    • 11 Jul 2011 Planned end date changed from 1 Feb 2012 to 1 Jun 2013 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top